1. Home
  2. IPAR vs NUVB Comparison

IPAR vs NUVB Comparison

Compare IPAR & NUVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Inter Parfums Inc.

IPAR

Inter Parfums Inc.

HOLD

Current Price

$85.32

Market Cap

2.6B

ML Signal

HOLD

NUVB

Nuvation Bio Inc.

HOLD

Current Price

$8.55

Market Cap

2.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IPAR
NUVB
Founded
1982
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Package Goods/Cosmetics
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
2.9B
IPO Year
1988
N/A

Fundamental Metrics

Financial Performance
Metric
IPAR
NUVB
Price
$85.32
$8.55
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
8
Target Price
$128.20
$10.63
AVG Volume (30 Days)
304.9K
6.0M
Earning Date
11-05-2025
11-03-2025
Dividend Yield
3.77%
N/A
EPS Growth
9.68
N/A
EPS
5.13
N/A
Revenue
$1,463,838,000.00
$26,748,000.00
Revenue This Year
$3.42
$609.55
Revenue Next Year
$1.53
$197.91
P/E Ratio
$16.55
N/A
Revenue Growth
3.12
1137.19
52 Week Low
$77.21
$1.54
52 Week High
$148.15
$9.75

Technical Indicators

Market Signals
Indicator
IPAR
NUVB
Relative Strength Index (RSI) 53.80 52.85
Support Level $84.16 $8.84
Resistance Level $86.18 $9.12
Average True Range (ATR) 2.00 0.45
MACD 0.42 -0.16
Stochastic Oscillator 75.97 26.29

Price Performance

Historical Comparison
IPAR
NUVB

About IPAR Inter Parfums Inc.

Interparfums Inc operates in the fragrance business and produces and distributes a wide array of prestige fragrance and fragrance-related products. It sells its product under the brand which includes Boucheron, Coach, Jimmy Choo, Karl Lagerfeld, Kate Spade, Lacoste, Lanvin, Moncler, Montblanc, Rochas and Van Cleef & Arpels. The company operates in two operating segments namely European based operations, SA, and United States based operations.. The group sells its products to department stores, perfumeries, specialty stores, and domestic and international wholesalers and distributors.

About NUVB Nuvation Bio Inc.

Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its product candidate, taletrectinib, is an oral, potent, central nervous system-active, selective, next-generation c-ros oncogene 1 (ROS1) inhibitor specifically designed for the treatment of patients with ROS1+ non-small cell lung cancer (NSCLC). In addition, its clinical-stage pipeline includes differentiated, novel oncology product candidates such as Safusidenib, NUV-1511, and NUV-868 in their different stages of development. The company generates revenue through out-licensing collaborative agreements with its customers located in China and Japan.

Share on Social Networks: